Monitoring and Updating Clinical AI

#What ongoing monitoring covers

Monitoring clinical AI means checking whether a system continues to function as intended in its actual setting. Technical checks may examine missing inputs, processing failures and response times. Clinical checks may examine performance, alert patterns and relevant outcomes. A functioning system can still be clinically unreliable, so technical availability is not enough.

Monitoring also considers who receives outputs and how people respond. Changes in workload, delays, overrides or access may reveal problems that a model score misses. Responsibilities, review schedules and routes for escalating concerns should be defined. The appropriate frequency depends on the use, potential harm and availability of reliable information.

#Detecting and investigating change

Drift describes changes in data or relationships that may affect performance. Teams can compare current input patterns and outcome frequencies with earlier periods. However, a detectable difference does not automatically mean the model has become unsafe, and stable input summaries do not prove that clinical performance is unchanged.

Reliable outcome labels may arrive only after substantial follow-up. Early indicators can prompt investigation, but they cannot always establish accuracy or benefit. Reassessment may include calibration, important error rates and subgroup performance. Findings need context because changes in patient populations, documentation or treatment can alter apparent results.

#Updating without losing control

An update might change data preparation, model parameters, probability calibration or decision thresholds. Each can affect outputs and clinical work. Controlled change involves documenting the reason, testing the revised system and deciding whether evidence supports its intended use. Updating should not be assumed to improve every measure or every group.

Version records help connect an output to the system that produced it. Plans may also include a way to return to an earlier version, pause use or follow a fallback process. After a change, monitoring remains necessary. Continuing use, revising the system and withdrawing it are all possible outcomes of reassessment.

#Common misunderstandings

Monitoring does not mean a clinical AI system learns automatically from every patient. Many systems stay unchanged until an update is deliberately introduced. Monitoring checks how a system performs in use; changing it is a separate process.

Good overall results do not establish that a system works equally well for every patient group or clinical setting. A stable average can hide poorer performance in smaller groups. Equally, a change in results does not necessarily mean the AI itself has deteriorated. Differences in patients, equipment, record keeping or clinical practice may help explain it.

An update is not automatically an improvement in every respect. Correcting one problem can introduce another, so changes need appropriate testing and review. Nor does an absence of reported incidents prove that a system is safe: problems may go unnoticed or unreported. Monitoring supports decisions about continued use, but it cannot remove all uncertainty or replace clinical judgement.

#Questions worth asking a clinician

• How do you check whether this AI system stays accurate for patients like me over time?
• What changes in patients, clinical practice or equipment could affect this AI system’s performance?
• How can I report a suspected AI error, and who investigates whether it affected my care?
• How are AI updates tested and approved before they are used in patient care?
• What findings would lead you to pause or stop using this AI system?